Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

How the Cow Ate the CABG: Aim Low, Live Longer?

Genest J, Bélanger AM, Sidhu MS.

J Am Coll Cardiol. 2019 Sep 3;74(9):1187-1189. doi: 10.1016/j.jacc.2019.07.016. No abstract available.

PMID:
31466615
3.

Response to "The effect of arteriovenous fistula (AVF) on hard endpoints should be observed prospectively in both CKD and non-CKD patients".

Mathew RO, Fleg J, Rangaswami J, Cai B, Asif A, Sidhu MS, Bangalore S.

Am J Hypertens. 2019 Jul 26. pii: hpz122. doi: 10.1093/ajh/hpz122. [Epub ahead of print] No abstract available.

PMID:
31346596
4.

Oral Anticoagulation for Atrial Fibrillation Thromboembolism Prophylaxis in the Chronic Kidney Disease Population: the State of the Art in 2019.

Zhang L, Steckman DA, Adelstein EC, Schulman-Marcus J, Loka A, Mathew RO, Venditti FJ, Sidhu MS.

Cardiovasc Drugs Ther. 2019 Aug;33(4):481-488. doi: 10.1007/s10557-019-06885-x.

PMID:
31165356
5.

Effect of Arteriovenous Fistula Creation on Systolic and Diastolic Blood Pressure in Patients With Pre-dialysis Advanced Chronic Kidney Disease.

Mathew RO, Fleg J, Rangaswami J, Cai B, Asif A, Sidhu MS, Bangalore S.

Am J Hypertens. 2019 Aug 14;32(9):858-867. doi: 10.1093/ajh/hpz081.

PMID:
31150056
6.

Attainment of Guideline-Directed Medical Treatment in Stable Ischemic Heart Disease Patients With and Without Chronic Kidney Disease.

Koutroumpakis E, Gosmanova EO, Stahura H, Jou S, Alreshq R, Ata A, Sidhu MS, Philbin E, Boden WE, Lyubarova R.

Cardiovasc Drugs Ther. 2019 Aug;33(4):443-451. doi: 10.1007/s10557-019-06883-z.

PMID:
31123935
7.

Time-resolved nano-Newton force spectroscopy in air and vacuum using a load cell of ultra micro-balance.

Panda B, Sidhu MS, Munjal P, Sokhi S, Singh KP.

Rev Sci Instrum. 2019 Apr;90(4):043117. doi: 10.1063/1.5086260.

PMID:
31043051
8.

Prosthetic fungal infections: poor prognosis with bacterial co-infection.

Sidhu MS, Cooper G, Jenkins N, Jeys L, Parry M, Stevenson JD.

Bone Joint J. 2019 May;101-B(5):582-588. doi: 10.1302/0301-620X.101B5.BJJ-2018-1202.R1.

PMID:
31039037
9.

Hyperkalemia Is Associated With Increased Mortality Among Unselected Cardiac Intensive Care Unit Patients.

Brueske B, Sidhu MS, Schulman-Marcus J, Kashani KB, Barsness GW, Jentzer JC.

J Am Heart Assoc. 2019 Apr 2;8(7):e011814. doi: 10.1161/JAHA.118.011814.

10.

Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.

Farkouh ME, Sidhu MS, Brooks MM, Vlachos H, Boden WE, Frye RL, Hartigan P, Siami FS, Bittner VA, Chaitman BR, Mancini GBJ, Fuster V.

J Am Coll Cardiol. 2019 Feb 5;73(4):400-411. doi: 10.1016/j.jacc.2018.11.044.

PMID:
30704571
11.

Systematic review of the effectiveness of community-based self-management interventions among primary care COPD patients.

Jolly K, Sidhu MS, Bates E, Majothi S, Sitch A, Bayliss S, Kim HJS, Jordan RE.

NPJ Prim Care Respir Med. 2018 Nov 23;28(1):44. doi: 10.1038/s41533-018-0111-9.

12.

In-Hospital Mortality and Major Adverse Cardiovascular Events after Kidney Transplantation in the United States.

Goyal A, Chatterjee K, Mathew RO, Sidhu MS, Bangalore S, McCullough PA, Rangaswami J.

Cardiorenal Med. 2019;9(1):51-60. doi: 10.1159/000492731. Epub 2018 Nov 14.

PMID:
30428461
13.

Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On Study.

Farkouh ME, Domanski M, Dangas GD, Godoy LC, Mack MJ, Siami FS, Hamza TH, Shah B, Stefanini GG, Sidhu MS, Tanguay JF, Ramanathan K, Sharma SK, French J, Hueb W, Cohen DJ, Fuster V; FREEDOM Follow-On Study Investigators.

J Am Coll Cardiol. 2019 Feb 19;73(6):629-638. doi: 10.1016/j.jacc.2018.11.001. Epub 2018 Nov 11.

PMID:
30428398
14.

Community acute kidney injury is associated with short- and long-term adverse outcomes in patients admitted with acute myocardial infarction
.

Mathew RO, Rangaswami J, Othersen JB, Cai B, Asif A, Sidhu MS, Bangalore S.

Clin Nephrol. 2018 Dec;90(6):404-412. doi: 10.5414/CN109548.

PMID:
30232954
15.

International Study of Comparative Health Effectiveness with Medical and Invasive Approaches-Chronic Kidney Disease (ISCHEMIA-CKD): Rationale and design.

Bangalore S, Maron DJ, Fleg JL, O'Brien SM, Herzog CA, Stone GW, Mark DB, Spertus JA, Alexander KP, Sidhu MS, Chertow GM, Boden WE, Hochman JS; ISCHEMIA-CKD Research Group.

Am Heart J. 2018 Nov;205:42-52. doi: 10.1016/j.ahj.2018.07.023. Epub 2018 Aug 1.

16.

TpTe and TpTe/QT: novel markers to predict sudden cardiac death in ESRD?

Saour BM, Wang JH, Lavelle MP, Mathew RO, Sidhu MS, Boden WE, Sacco JD, Costanzo EJ, Hossain MA, Vachharanji T, Alrefaee A, Asif A.

J Bras Nefrol. 2019 Jan-Mar;41(1):38-47. doi: 10.1590/2175-8239-JBN-2017-0021. Epub 2018 Aug 16. English, Portuguese.

17.

Detection of Atherosclerotic Cardiovascular Disease in Patients with Advanced Chronic Kidney Disease in the Cardiology and Nephrology Communities.

Chaudhry RI, Mathew RO, Sidhu MS, Sidhu-Adler P, Lyubarova R, Rangaswami J, Salman L, Asif A, Fleg JL, McCullough PA, Maddux F, Bangalore S.

Cardiorenal Med. 2018;8(4):285-295. doi: 10.1159/000490768. Epub 2018 Aug 3.

19.

Self management of patients with mild COPD in primary care: randomised controlled trial.

Jolly K, Sidhu MS, Hewitt CA, Coventry PA, Daley A, Jordan R, Heneghan C, Singh S, Ives N, Adab P, Jowett S, Varghese J, Nunan D, Ahmed K, Dowson L, Fitzmaurice D.

BMJ. 2018 Jun 13;361:k2241. doi: 10.1136/bmj.k2241.

20.

Increasing inclusion of patients with advanced chronic kidney disease in cardiovascular clinical trials.

Mathew RO, Bangalore S, Sidhu MS, Fleg JL, Maddux FW.

Kidney Int. 2018 Apr;93(4):787-788. doi: 10.1016/j.kint.2017.11.028. No abstract available.

PMID:
29571453
22.

Chelation Therapy as a Cardiovascular Therapeutic Strategy: the Rationale and the Data in Review.

Mathew RO, Schulman-Marcus J, Nichols EL, Newman JD, Bangalore S, Farkouh M, Sidhu MS.

Cardiovasc Drugs Ther. 2017 Dec;31(5-6):619-625. doi: 10.1007/s10557-017-6759-5. Review.

PMID:
29129003
23.

The processing and heterostructuring of silk with light.

Sidhu MS, Kumar B, Singh KP.

Nat Mater. 2017 Sep;16(9):938-945. doi: 10.1038/nmat4942. Epub 2017 Aug 14.

PMID:
28805825
24.

Subcutaneous defibrillators for dialysis patients.

Vachharajani TJ, Salman L, Costanzo EJ, Mehandru SK, Patel M, Calderon DM, Mathew RO, Sidhu MS, Asif A.

Hemodial Int. 2018 Jan;22(1):4-8. doi: 10.1111/hdi.12577. Epub 2017 Jun 23. Review.

PMID:
28643860
25.

The association of QRS duration with atrial fibrillation in a heart failure with preserved ejection fraction population: a pilot study.

Gigliotti JN, Sidhu MS, Robert AM, Zipursky JS, Brown JR, Costa SP, Palac RT, Steckman DA, Malenka DJ, Kono AT, Greenberg ML.

Clin Cardiol. 2017 Oct;40(10):861-864. doi: 10.1002/clc.22736. Epub 2017 Jun 6.

26.

The Role of SGLT-2 Inhibitors as Part of Optimal Medical Therapy in Improving Cardiovascular Outcomes in Patients with Diabetes and Coronary Artery Disease.

Mosleh W, Sharma A, Sidhu MS, Page B, Sharma UC, Farkouh ME.

Cardiovasc Drugs Ther. 2017 Jun;31(3):311-318. doi: 10.1007/s10557-017-6729-y. Review.

PMID:
28536852
27.

The Role of Nitrates in the Management of Stable Ischemic Heart Disease: A Review of the Current Evidence and Guidelines.

Pragani MA, Desai KP, Morrone D, Sidhu MS, Boden WE.

Rev Cardiovasc Med. 2017;18(1):14-20. Review.

PMID:
28509889
28.

Antianginal Therapy for Stable Ischemic Heart Disease: A Contemporary Review.

Padala SK, Lavelle MP, Sidhu MS, Cabral KP, Morrone D, Boden WE, Toth PP.

J Cardiovasc Pharmacol Ther. 2017 Nov;22(6):499-510. doi: 10.1177/1074248417698224. Epub 2017 Mar 31. Review.

PMID:
28361599
29.

Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review.

Mathew RO, Bangalore S, Lavelle MP, Pellikka PA, Sidhu MS, Boden WE, Asif A.

Kidney Int. 2017 Apr;91(4):797-807. doi: 10.1016/j.kint.2016.09.049. Epub 2016 Dec 28. Review.

PMID:
28040264
30.

Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis.

Padala SK, Peaslee S, Sidhu MS, Steckman DA, Judson MA.

Int J Cardiol. 2017 Jan 15;227:565-570. doi: 10.1016/j.ijcard.2016.10.101. Epub 2016 Nov 2.

PMID:
27836297
31.

Non-diagnostic coronary artery calcification and stenosis: a correlation of coronary computed tomography angiography and invasive coronary angiography.

Engel LC, Thai WE, Medina-Zuluaga H, Karolyi M, Sidhu MS, Maurovich-Horvat P, Margey R, Pomerantsev E, Abbara S, Ghoshhajra BB, Hoffmann U, Liew GY.

Acta Radiol. 2017 May;58(5):528-536. doi: 10.1177/0284185116663041. Epub 2016 Sep 30.

PMID:
27614067
32.

Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.

Mancini GB, Farkouh ME, Brooks MM, Chaitman BR, Boden WE, Vlachos H, Hartigan PM, Siami FS, Sidhu MS, Bittner V, Frye R, Fuster V.

J Am Coll Cardiol. 2016 Sep 6;68(10):985-95. doi: 10.1016/j.jacc.2016.06.021.

33.

Hospital Advertising, Competition, and HCAHPS: Does It Pay to Advertise?

Huppertz JW, Bowman RA, Bizer GY, Sidhu MS, McVeigh C.

Health Serv Res. 2017 Aug;52(4):1590-1611. doi: 10.1111/1475-6773.12549. Epub 2016 Aug 22.

34.

Predictors of Initial Revascularization Versus Medical Therapy Alone in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing an Invasive Strategy.

Wijeysundera HC, Sidhu MS, Bennell MC, Qiu F, Ko DT, Knudtson ML, Tu JV, Boden WE.

Circ Cardiovasc Interv. 2016 Jul;9(7). pii: e003592. doi: 10.1161/CIRCINTERVENTIONS.115.003592.

PMID:
27418612
35.

Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS Trial.

Hagström E, Roe MT, Hafley G, Neely ML, Sidhu MS, Winters KJ, Prabhakaran D, White HD, Armstrong PW, Fox KA, Ohman EM, Boden WE; TRILOGY ACS Investigators.

Clin Cardiol. 2016 Jun;39(6):329-37. doi: 10.1002/clc.22533. Epub 2016 May 13.

36.

Evaluation of a text supported weight maintenance programme 'Lighten Up Plus' following a weight reduction programme: randomised controlled trial.

Sidhu MS, Daley A, Jolly K.

Int J Behav Nutr Phys Act. 2016 Feb 12;13:19. doi: 10.1186/s12966-016-0346-1.

37.

Long-term conditions, self-management and systems of support: an exploration of health beliefs and practices within the Sikh community, Birmingham, UK.

Sidhu MS, Griffith L, Jolly K, Gill P, Marshall T, Gale NK.

Ethn Health. 2016 Oct;21(5):498-514. doi: 10.1080/13557858.2015.1126560. Epub 2016 Jan 13.

PMID:
26758646
38.

Selective disruption of vascular endothelium of zebrafish embryos by ultrafast laser microsurgical treatment.

Woo SY, Moon HY, Kim TG, Lee HS, Sidhu MS, Kim C, Jeon JP, Jeoung SC.

Biomed Opt Express. 2015 Nov 4;6(12):4694-704. doi: 10.1364/BOE.6.004694. eCollection 2015 Dec 1.

39.

Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?

Cheng-Torres KA, Desai KP, Sidhu MS, Maron DJ, Boden WE.

Future Cardiol. 2016 Jan;12(1):35-44. doi: 10.2217/fca.15.57. Epub 2015 Dec 21.

PMID:
26696561
40.

Acute Coronary Syndrome: An Unusual Consequence of GERD.

Hui CM, Padala SK, Lavelle M, Torosoff MT, Zhu XC, Sidhu MS.

Case Rep Cardiol. 2015;2015:939641. doi: 10.1155/2015/939641. Epub 2015 Nov 24.

41.

Non-sustained wide complex tachycardia: an underappreciated sign to aid in diagnosis.

Padala SK, Sidhu MS, Brown JR, Zipursky JS, Steckman DA, Parikh DR, Greenberg ML.

Europace. 2016 Jul;18(7):1069-76. doi: 10.1093/europace/euv273. Epub 2015 Dec 17.

PMID:
26678080
42.

Lyme Carditis in the Fast Lane: From Alternating Bundle Branch Block to Asystole in 12 Hours.

Khalil S, Padala SK, Hui CM, Steckman DA, Sidhu MS, Torosoff MT.

Conn Med. 2015 Oct;79(9):517-20.

PMID:
26630701
43.

Effect of baseline exercise capacity on outcomes in patients with stable coronary heart disease (a post hoc analysis of the clinical outcomes utilizing revascularization and aggressive drug evaluation trial).

Padala SK, Sidhu MS, Hartigan PM, Maron DJ, Teo KK, Spertus JA, Mancini GB, Sedlis SP, Chaitman BR, Heller GV, Weintraub WS, Boden WE.

Am J Cardiol. 2015 Nov 15;116(10):1509-15. doi: 10.1016/j.amjcard.2015.08.012. Epub 2015 Aug 31.

44.

Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize.

Torosoff MT, Sidhu MS, Desai KP, Fein SA, Boden WE.

J Comp Eff Res. 2015 Sep;4(5):505-14. doi: 10.2217/cer.15.37. Epub 2015 Sep 21. Review.

PMID:
26387530
45.

Dynamic changes in PDMS surface morphology in femtosecond laser treatment.

Moon HY, Sidhu MS, Lee HS, Jeoung SC.

Opt Express. 2015 Jul 27;23(15):19854-62. doi: 10.1364/OE.23.019854.

PMID:
26367645
46.

Role of short-acting nitroglycerin in the management of ischemic heart disease.

Boden WE, Padala SK, Cabral KP, Buschmann IR, Sidhu MS.

Drug Des Devel Ther. 2015 Aug 19;9:4793-805. doi: 10.2147/DDDT.S79116. eCollection 2015. Review.

47.

Antianginal Agents for the Management of Stable Ischemic Heart Disease: A Review.

Mody P, Sidhu MS, Brilakis ES, Sacco JD, Banerjee S, Boden WE.

Cardiol Rev. 2016 Jul-Aug;24(4):177-89. doi: 10.1097/CRD.0000000000000085. Review.

PMID:
26274534
48.

Is HPS2-THRIVE the death knell for niacin?

Toth PP, Murthy AM, Sidhu MS, Boden WE.

J Clin Lipidol. 2015 May-Jun;9(3):343-50. doi: 10.1016/j.jacl.2015.01.008. Epub 2015 Jan 30. Review.

PMID:
26073392
49.

A Review of the Use of Iloprost, A Synthetic Prostacyclin, in the Prevention of Radiocontrast Nephropathy in Patients Undergoing Coronary Angiography and Intervention.

Kassis HM, Minsinger KD, McCullough PA, Block CA, Sidhu MS, Brown JR.

Clin Cardiol. 2015 Aug;38(8):492-8. doi: 10.1002/clc.22407. Epub 2015 May 12. Review.

50.

The continued importance of optimal medical therapy with or without revascularization in diabetic patients with coronary artery disease.

Sidhu MS, Boden WE.

Trends Cardiovasc Med. 2015 Oct;25(7):632-4. doi: 10.1016/j.tcm.2015.04.002. Epub 2015 Apr 10. No abstract available.

PMID:
25957809

Supplemental Content

Loading ...
Support Center